Emotional Intelligence Ventures Raises $20 Million To Pursue Psilocybin Transdermal Delivery Research

Emotional Intelligence Ventures (Ei.Ventures) has raised more than $20.1 million in a Regulation A funding round, with the goal of raising nearly $50 million to purse development of a psilocybin transdermal delivery system and nutraceuticals. A Regulation A offering allows for retail investors to invest in pre-public and private companies, such as Ei.Ventures. The net proceeds of the offering will be used to accelerate the development and distribution of Ei’s medicinal and functional psilocybin mushroom product lines.

As part of its research and development into natural psychedelic compounds, Ei.Ventures partnered with Tioga Research to . . .